GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Guangdong Hybribio Biotech Co Ltd (SZSE:300639) » Definitions » 1-Year Sharpe Ratio

Guangdong Hybribio Biotech Co (SZSE:300639) 1-Year Sharpe Ratio : 0.07 (As of Jul. 04, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Guangdong Hybribio Biotech Co 1-Year Sharpe Ratio?

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2025-07-04), Guangdong Hybribio Biotech Co's 1-Year Sharpe Ratio is 0.07.


Competitive Comparison of Guangdong Hybribio Biotech Co's 1-Year Sharpe Ratio

For the Diagnostics & Research subindustry, Guangdong Hybribio Biotech Co's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangdong Hybribio Biotech Co's 1-Year Sharpe Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Guangdong Hybribio Biotech Co's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Guangdong Hybribio Biotech Co's 1-Year Sharpe Ratio falls into.


;
;

Guangdong Hybribio Biotech Co 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.


Guangdong Hybribio Biotech Co  (SZSE:300639) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


Guangdong Hybribio Biotech Co 1-Year Sharpe Ratio Related Terms

Thank you for viewing the detailed overview of Guangdong Hybribio Biotech Co's 1-Year Sharpe Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangdong Hybribio Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
D 5-3-3-4, North High-tech Zone, Economic Development Zone, Chaozhou City, CHN, 521000
Guangdong Hybribio Biotech Co Ltd is a Chinese company engaged in offering vitro diagnostic assays. Its products include in-vitro diagnostic kits, female sample collection kit, DNA extraction kit, and other devices. The company's products help in the infectious pathogens detection and genetic disease detection, including human papillomavirus, thalassemia, G6PD, hearing loss susceptibility, phenylketonuria, and early cancer detection, among others. The company has a business presence in China and various other countries.
Executives
Xie Long Xu Directors, executives
Li Qing Hui Executives
Wang Jian Yu Directors, executives
Guan Zhi Sheng Directors, executives
Qiu Mei Lan Supervisors
Yuan Xian Securities Affairs Representative
Tang You Gen Independent director
Cai Dan Ping Director
Chen Yi Directors, executives
Xu Wan Jian Supervisors
Huang Wei Xiong Director
Guan Qiao Zhong Directors, executives

Guangdong Hybribio Biotech Co Headlines

No Headlines